Cargando…
Vincristine therapy for severe and refractory immune thrombocytopenia following COVID-19 vaccination
Autores principales: | Saito, Kei, Ichikawa, Satoshi, Hatta, Shunsuke, Katsuoka, Yuna, Harigae, Hideo, Izumi, Tohru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485970/ https://www.ncbi.nlm.nih.gov/pubmed/34599382 http://dx.doi.org/10.1007/s00277-021-04666-x |
Ejemplares similares
-
T-Cell/Histiocyte-Rich Large B-Cell Lymphoma of the Thyroid
por: Ichikawa, Satoshi, et al.
Publicado: (2013) -
Dynamics of absorption, metabolism, and excretion of 5-aminolevulinic acid in human intestinal Caco-2 cells
por: Saito, Kei, et al.
Publicado: (2017) -
Application of vincristine-loaded platelet therapy in three dogs with refractory immune-mediated thrombocytopenia
por: Park, Hyung-Jin, et al.
Publicado: (2015) -
Expression profiling of ETO2-regulated miRNAs in erythroid cells: Possible influence on miRNA abundance()
por: Fujiwara, Tohru, et al.
Publicado: (2013) -
Successful Treatment of Aggressive Mature B-cell Lymphoma Mimicking Immune Thrombocytopenic Purpura
por: Ono, Koya, et al.
Publicado: (2018)